Form 4 Tracker
UNITED THERAPEUTICS Corp
UTHR

146 insider filings · Latest: Jun 18, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 15, 2026May 18 10:18 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$568.11$5.4M40,513(D)

View →

May 14, 2026May 15 9:04 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$574.48$5.5M40,513(D)

View →

May 14, 2026May 15 9:04 PMJames EdgemondCFO AND TREASURER
Sale
10,000$574.47$5.7M18,876(D)

View →

May 13, 2026May 14 9:54 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$578.65$5.5M40,513(D)

View →

May 12, 2026May 13 8:31 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$578.38$5.5M40,513(D)

View →

May 12, 2026May 13 8:31 PMNilda MesaDirector
Sale
258$581.94$150.1K5,028(D)

View →

May 11, 2026May 12 9:25 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$573.10$5.4M40,513(D)

View →

May 11, 2026May 12 9:25 PMJames EdgemondCFO AND TREASURER
Sale
10,000$573.03$5.7M18,876(D)

View →

May 12, 2026May 12 9:16 PMNILDA MESA
Proposed Sale
258$581.94$150.1K

View →

May 8, 2026May 11 8:30 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$564.95$5.4M40,513(D)

View →

May 7, 2026May 11 11:37 AMJames EdgemondCFO AND TREASURER
Sale
10,000$578.58$5.8M18,876(D)

View →

May 7, 2026May 11 11:36 AMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$578.54$5.5M40,513(D)

View →

May 7, 2026May 7 8:31 PMPaul A MahonEVP & GENERAL COUNSEL
Sale
8,300$586.75$4.9M45,172(D)

View →

May 6, 2026May 7 8:30 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$589.52$5.6M40,513(D)

View →

May 7, 2026May 7 8:04 PMPAUL MAHON
Proposed Sale
8,300$586.75$4.9M

View →

May 5, 2026May 6 9:04 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$576.24$5.5M40,513(D)

View →

May 4, 2026May 5 8:31 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$576.97$5.5M40,513(D)

View →

May 4, 2026May 5 8:30 PMJames EdgemondCFO AND TREASURER
Sale
10,000$576.93$5.8M18,876(D)

View →

May 1, 2026May 4 8:54 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$570.58$5.4M40,513(D)

View →

May 4, 2026May 4 8:52 PMJAMES C EDGEMOND
Proposed Sale
148,750$570.40$84.8M

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 4, 2026Mar 5 9:35 PMTommy G ThompsonDirector
Option Exercise
2,000$101.802,000(D)

View →

Mar 4, 2026Mar 5 9:34 PMChristopher CauseyDirector
Option Exercise
20$119.766,300(D)

View →

Mar 3, 2026Mar 5 9:33 PMMartine A RothblattDirector, Chairperson & CEO
Option Exercise
9,500$146.03221,000(D)

View →

Mar 2, 2026Mar 3 9:31 PMMartine A RothblattDirector, Chairperson & CEO
Option Exercise
9,500$146.03230,500(D)

View →

Mar 15, 2023Feb 26 9:31 PMPaul A MahonEVP & GENERAL COUNSEL
Grant/Award
66,551$217.508,895(D)

View →

Mar 15, 2023Feb 26 9:31 PMMartine A RothblattDirector, Chairperson & CEO
Grant/Award
277,299$217.5037,080(D)

View →

Mar 15, 2023Feb 26 9:30 PMMichael BenkowitzPRESIDENT AND COO
Grant/Award
133,102$217.5017,790(D)

View →

Mar 15, 2023Feb 26 9:30 PMJames EdgemondCFO AND TREASURER
Grant/Award
77,648$217.5010,380(D)

View →

Feb 25, 2026Feb 25 9:31 PMChristopher CauseyDirector
Option Exercise
1,000$119.766,320(D)

View →

Feb 23, 2026Feb 24 9:31 PMMichael BenkowitzPRESIDENT AND COO
Option Exercise
14,440$146.030(I)

View →

Feb 19, 2026Feb 19 9:31 PMPaul A MahonEVP & GENERAL COUNSEL
Option Exercise
8,300$146.0341,800(D)

View →

Feb 17, 2026Feb 18 9:31 PMMichael BenkowitzPRESIDENT AND COO
Option Exercise
22,500$146.035,065(I)

View →

Feb 9, 2026Feb 10 9:30 PMMichael BenkowitzPRESIDENT AND COO
Option Exercise
22,500$146.0312,940(I)

View →

Feb 5, 2026Feb 5 9:31 PMPaul A MahonEVP & GENERAL COUNSEL
Option Exercise
8,300$146.0350,100(D)

View →

Feb 2, 2026Feb 3 9:31 PMMichael BenkowitzPRESIDENT AND COO
Option Exercise
22,500$146.0320,815(I)

View →

Jan 26, 2026Jan 28 9:31 PMMichael BenkowitzPRESIDENT AND COO
Option Exercise
22,500$146.0328,690(I)

View →

Jan 20, 2026Jan 28 9:31 PMMichael BenkowitzPRESIDENT AND COO
Option Exercise
7,875$146.0336,565(I)

View →

Jan 20, 2026Jan 28 9:30 PMMichael BenkowitzPRESIDENT AND COO
Option Exercise
14,625$146.0367,875(I)

View →

Jan 21, 2026Jan 23 9:32 PMKevin TraceyDirector
Grant/Award
1,2201,220(D)

View →

← Previous

Page 7 of 7